H-151
Based on 158 publication(s) in Google Scholar
H-151 is a potent, selective and covalent antagonist of STING that has noteworthy inhibitory activity both in cells and in vivo. H-151 reduces TBK1 phosphorylation and suppresses STING palmitoylation. H-151 can be used for the research of autoinflammatory disease.
For research use only. We do not sell to patients.
- Purity: 99.78%
- CAS No.: 941987-60-6
- Formula: C17H17N3O
- Molecular Weight:279.34
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) H-151
More- Signal Transduct Target Ther. 2025 Oct 1;10(1):321. [Abstract]
- Signal Transduct Target Ther. 2025 May 28;10(1):167. [Abstract]
- Science. 2026 Feb 26;391(6788):eads4405. [Abstract]
- Nat Biotechnol. 2025 Oct 2. [Abstract]
- Cell Metab. 2025 Dec 3:S1550-4131(25)00486-3. [Abstract]
- Cell Metab. 2021 Oct 5;33(10):2076-2089.e9. [Abstract]
- Adv Mater. 2025 Apr;37(17):e2410998. [Abstract]
- Immunity. 2025 Dec 5:S1074-7613(25)00506-0. [Abstract]
- Immunity. 2024 Jun 19:S1074-7613(24)00305-4. [Abstract]
- Exploration. 2025 Dec 18;5(6):20240396. [Abstract]
- Cell Stem Cell. 2025 Apr 3;32(4):581-597.e11. [Abstract]
- Nat Aging. 2026 Apr;6(4):831-848. [Abstract]
- Mol Cell. 2026 Jun 18;86(12):2294-2308.e7. [Abstract]
- Cancer Res. 2025 Apr 15;85(8):1441-1458. [Abstract]
- Cancer Res. 2021 May 15;81(10):2714-2729. [Abstract]
- Nat Commun. 2026 Feb 9;17(1):2543. [Abstract]
- Nat Commun. 2025 Oct 29;16(1):9547. [Abstract]
- Cell Death Differ. 2026 Apr 1. [Abstract]
- Neuron. 2023 Jan 18;111(2):236-255.e7. [Abstract]
- Adv Sci (Weinh). 2025 Sep 8:e02223. [Abstract]
- Adv Sci (Weinh). 2024 Jun 18:e2401634. [Abstract]
- Leukemia. 2023 Dec;37(12):2457-2467. [Abstract]
- Exp Mol Med. 2022 Feb;54(2):129-142. [Abstract]
- J Nanobiotechnology. 2023 Oct 19;21(1):382. [Abstract]
- Sci Adv. 2025 Jul 11;11(28):eadw1553. [Abstract]
- Small. 2024 Mar;20(9):e2307448. [Abstract]
- Cell Rep Med. 2026 Apr 21;7(4):102714. [Abstract]
- Cell Rep Med. 2025 May 20;6(5):102135. [Abstract]
- J Immunother Cancer. 2024 Nov 9;12(11):e009212. [Abstract]
- J Immunother Cancer. 2024 Sep 4;12(9):e009318. [Abstract]
- J Immunother Cancer. 2023 Aug;11(8):e007035. [Abstract]
- Diabetologia. 2025 Dec 19. [Abstract]
- Cancer Lett. 2025 Apr 29:217759. [Abstract]
- J Neuroinflammation. 2024 Apr 8;21(1):86. [Abstract]
- Int J Biol Sci. 2024 Sep 3;20(12):4713-4730. [Abstract]
- Int J Biol Sci. 2022 Jan 1;18(2):585-598. [Abstract]
- Cell Death Dis. 2026 Mar 25;17(1):377. [Abstract]
- Adv Healthc Mater. 2026 Apr;15(16):e05898. [Abstract]
- Cell Death Dis. 2024 Mar 8;15(3):195. [Abstract]
- Cell Death Dis. 2024 Feb 3;15(2):110. [Abstract]
- Genes Dis. 2025 Aug 14.
- Proc Natl Acad Sci U S A. 2023 Jan 31;120(5):e2213777120. [Abstract]
- Cell Commun Signal. 2025 Feb 19;23(1):99. [Abstract]
- Cell Commun Signal. 2023 Aug 3;21(1):192. [Abstract]
- Int J Biol Macromol. 2024 Sep 17:135764. [Abstract]
- Acta Pharmacol Sin. 2025 Apr 8. [Abstract]
- Acta Pharmacol Sin. 2022 Aug;43(8):2055-2066. [Abstract]
- Phytomedicine. 2026 Jun 9:159:158399. [Abstract]
- EMBO J. 2025 Sep 1. [Abstract]
- Phytomedicine. 2025 Jan 17:138:156403. [Abstract]
- ACS Appl Mater Interfaces. 2026 Apr 29;18(16):22999-23016. [Abstract]
- Cancer Immunol Res. 2025 Nov 11. [Abstract]
- Free Radic Biol Med. 2025 Oct 25.
- Free Radic Biol Med. 2025 Mar 28:S0891-5849(25)00192-3. [Abstract]
- Free Radic Biol Med. 2025 Jan:226:288-301. [Abstract]
- Free Radic Biol Med. 2023 Nov 1:208:348-360. [Abstract]
- Sci Total Environ. 2023 Dec 20:905:167315. [Abstract]
- Chin Med J (Engl). 2026 Apr 27. [Abstract]
- Cell Chem Biol. 2026 Apr 27:S2451-9456(26)00110-8. [Abstract]
- Aging Cell. 2026 Jan;25(1):e70350. [Abstract]
- Cell Death Discov. 2023 Nov 18;9(1):419. [Abstract]
- Cell Death Discov. 2023 Oct 4;9(1):368. [Abstract]
- Cell Rep. 2025 Apr 17;44(5):115605. [Abstract]
- Cell Rep. 2024 Dec 21;44(1):115094. [Abstract]
- Cell Rep. 2023 Feb 28;42(3):112145. [Abstract]
- Neural Regen Res. 2025 Aug 1;20(8):2361-2372. [Abstract]
- Antioxidants (Basel). 2026 Mar 16;15(3):374. [Abstract]
- EMBO Rep. 2022 Jun 7;23(6):e53932. [Abstract]
- JCI Insight. 2025 Jan 23;10(2):e180248. [Abstract]
- Antioxid Redox Signal. 2024 Aug 1. [Abstract]
- Neurosci Bull. 2025 Mar;41(3):359-373. [Abstract]
- Biochem Pharmacol. 2026 Mar 8:249:117879. [Abstract]
- Biochem Pharmacol. 2025 Dec;242(Pt 3):117406. [Abstract]
- Biochem Pharmacol. 2023 Jul:213:115618. [Abstract]
- Pak Vet J. 2026 Feb 19;46(2):361-372.
- Virulence. 2025 Dec;16(1):2570001. [Abstract]
- Int J Pharm. 2024 Dec 5:666:124759. [Abstract]
- Int J Pharm. 2023 Apr 5:636:122847. [Abstract]
- Life Sci. 2026 Apr 15:391:124281. [Abstract]
- Commun Biol. 2025 Aug 23;8(1):1266. [Abstract]
- Prog Orthod. 2026 Jan 13;27(1):1. [Abstract]
- Int J Mol Sci. 2023 Mar 7;24(6):5125. [Abstract]
- Int Immunopharmacol. 2026 Sep 1:184:116954. [Abstract]
- Int Immunopharmacol. 2026 Aug 1:182:116798. [Abstract]
- Int Immunopharmacol. 2026 Mar 1:172:116229. [Abstract]
- Eur J Pharmacol. 2026 Feb 15:1015:178564. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 2):115892. [Abstract]
- Int Immunopharmacol. 2025 Oct 22:167:115717. [Abstract]
- Am J Physiol Cell Physiol. 2025 Sep 12. [Abstract]
- Eur J Pharmacol. 2025 Mar 25:177537. [Abstract]
- Int Immunopharmacol. 2024 Oct 17;143(Pt 2):113401. [Abstract]
- Int Immunopharmacol. 2024 Sep 22;142(Pt B):113171. [Abstract]
- Int Immunopharmacol. 2024 Jun 24:138:112515. [Abstract]
- Eur J Pharmacol. 2024 Jun 5:176716. [Abstract]
- Int Immunopharmacol. 2024 Jan 25:127:111262. [Abstract]
- Mol Pharm. 2025 Apr 7;22(4):2108-2121. [Abstract]
- Mol Oncol. 2023 Dec;17(12):2584-2602. [Abstract]
- Exp Gerontol. 2026 Jun 15:219:113157. [Abstract]
- J Gen Virol. 2026 Mar;107(3):002233. [Abstract]
- Drug Dev Res. 2026 May;87(3):e70311. [Abstract]
- Exp Neurol. 2026 May 11;403:115804.
- J Cell Mol Med. 2025 Aug;29(15):e70728. [Abstract]
- FASEB J. 2025 Apr 15;39(7):e70530. [Abstract]
- FEBS J. 2025 Apr 22. [Abstract]
- Transl Oncol. 2026 Jun 19:71:102869. [Abstract]
- iScience. 2025 Sep 5;28(10):113517. [Abstract]
- Eye Vis (Lond). 2026 Feb 2;13(1):7. [Abstract]
- Pestic Biochem Physiol. 2024 Nov:205:106129. [Abstract]
- Sci Rep. 2026 Mar 11;16(1):13082. [Abstract]
- J Virol. 2023 Sep 28;97(9):e0057723. [Abstract]
- Clin Immunol. 2023 May:250:109300. [Abstract]
- Front Mol Neurosci. 2022 Apr 14:15:859166. [Abstract]
- Cell Signal. 2026 Aug:144:112517. [Abstract]
- Cell Signal. 2025 Jun 16:111948. [Abstract]
- Cell Signal. 2023 Sep:109:110777. [Abstract]
- Am J Pathol. 2026 Feb;196(2):515-531. [Abstract]
- Heliyon. 2024 Dec 26;11(1):e41501. [Abstract]
- Biol Trace Elem Res. 2025 Aug;203(8):4224-4239. [Abstract]
- BMC Cancer. 2024 Jul 26;24(1):902. [Abstract]
- J Immunol. 2021 Apr 15;206(8):1844-1857. [Abstract]
- Am J Physiol Renal Physiol. 2021 Apr 1;320(4):F608-F616. [Abstract]
- Cell Biol Int. 2026 Feb;50(2):e70130. [Abstract]
- J Diabetes Investig. 2025 Nov 25. [Abstract]
- Ren Fail. 2024 Dec;46(2):2363591. [Abstract]
- Toxicol Lett. 2026 Mar:417:111847. [Abstract]
- 3 Biotech. 2025 Aug;15(8):236. [Abstract]
- Toxicol Lett. 2023 Jan 15:373:172-183. [Abstract]
- BMC Pulm Med. 2025 Nov 7;25(1):514. [Abstract]
- Neuroscience. 2025 Apr 19:572:122-133. [Abstract]
- J Pharm Innov. 2026 Jun 24;21(6):638.
- Toxicol Mech Methods. 2026 May;36(4):594-604. [Abstract]
- Cell Biochem Funct. 2025 Jun;43(6):e70092. [Abstract]
- Photodiagnosis Photodyn Ther. 2026 Jun 2:60:105534. [Abstract]
- Adv Biol (Weinh). 2024 Jun 12:e2300711. [Abstract]
- J Neuroimmunol. 2024 Dec 15:397:578469. [Abstract]
- Purinergic Signal. 2026 Mar 30;22(2):35. [Abstract]
- J Biomol Struct Dyn. 2025 May 27:1-14. [Abstract]
- Exp Ther Med. 2023 Feb 17;25(4):155. [Abstract]
- Gastroenterol Res Pract. 2025 Feb 26:2025:4950214. [Abstract]
- bioRxiv. 2026 May 25:2026.05.24.727547. [Abstract]
- bioRxiv. 2026 May 29:2026.05.26.727520. [Abstract]
- bioRxiv. 2026 Apr 25:2026.04.23.719926. [Abstract]
- Res Sq. 2026 Jan 22.
- SSRN. 2025 Dec 15.
- Res Sq. 2025 Oct 6.
- SSRN. 2025 Sep 10.
- SSRN. 2025 Aug 9.
- bioRxiv. 2025 July 17.
- Cell Insight. 2025 May 22;4(4):100255. [Abstract]
- SSRN. 2025 Jan 24.
- bioRxiv. 2025 Feb 5:2025.01.31.635709. [Abstract]
- Res Sq. 2024 Nov 12.
- bioRxiv. 2024 Sep 5:2024.09.05.611469. [Abstract]
- SSRN. 2024 MAY 30.
- bioRxiv. 2023 Sep 5:2023.09.04.556156. [Abstract]
- Research Square Preprint. 2023 May 3.
- SSRN. Posted: 3 Nov 202
- Research Square Print. 2022 May.
-
WB
-
Cell Proliferation/Viability Assay
-
WB
-
IF
-
WB
Biological Activity
STING[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BMDM | IC50 |
502.8 μM
Compound: 24; H-151
|
Cytotoxicity against mouse BMDM cells assessed as cell viability
Cytotoxicity against mouse BMDM cells assessed as cell viability
|
[PMID: 35635952] |
| HFF | IC50 |
134.4 μM
Compound: 24; H-151
|
Cytotoxicity against HFF cells assessed as cell viability
Cytotoxicity against HFF cells assessed as cell viability
|
[PMID: 35635952] |
| MEF | IC50 |
109.6 μM
Compound: 24; H-151
|
Cytotoxicity against MEF cells assessed as cell viability
Cytotoxicity against MEF cells assessed as cell viability
|
[PMID: 35635952] |
H-151 (0.02-2 μM) reduces IFNβ luciferase reporter measurements of HEK293T cells[1].
H-151 (0.5 μM; 2 h) inhibits the phosphorylation of TBK1 in THP-1 cells[1].
H-151 (1 μM; 3 h) suppresses hsSTING palmitoylation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
H-151 (750 nmol per mouse; i.p. daily for 7 d) exhibits notable efficacy in Trex1 / mice that expressed a bioluminescent IFNβ reporter[1].
H-151 (750 nmol per mouse; i.p.) reaches effective systemic levels, displays a short half-life in the serum and forms an adduct to mmSTING in wild-type mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 941987-60-6
-
Appearance Solid
-
Molecular Weight 279.34
-
Formula C17H17N3O
-
Color White to off-white
-
SMILES
O=C(NC1=CNC2=C1C=CC=C2)NC3=CC=C(CC)C=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (158)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
Inhibition of long interspersed nuclear element-1 by nucleoside reverse transcriptase inhibitors attenuates vascular calcification. [Abstract]2025 Oct 1;10(1):321. PMID: 41027876 -
Signal Transduct Target Ther
Arginase 1 drives mitochondrial cristae remodeling and PANoptosis in ischemia/hypoxia-induced vascular dysfunction. [Abstract]2025 May 28;10(1):167. PMID: 40425583 -
Science
2026 Feb 26;391(6788):eads4405. PMID: 41747053 -
Nat Biotechnol
2025 Oct 2. PMID: 41039042 -
Cell Metab
Excessive vigorous exercise impairs cognitive function through a muscle-derived mitochondrial pretender. [Abstract]2025 Dec 3:S1550-4131(25)00486-3. PMID: 41344322 -
Cell Metab
Innate immune response orchestrates phosphoribosyl pyrophosphate synthetases to support DNA repair. [Abstract]2021 Oct 5;33(10):2076-2089.e9. PMID: 34343500
H-151 purchased from MedChemExpress. Usage Cited in: Cell Metab. 2021 Oct 5;33(10):2076-2089.e9. [Abstract]
FHs 74 Int cells were pretreated with 1 μM H-151 or 4 μM C-170 for 2 h and then exposed to 10 Gy ionizing radiation. IFNb expression was examined by qPCR 2 h after irradiation.
-
Adv Mater
A Polymeric mRNA Vaccine Featuring Enhanced Site-Specific mRNA Delivery and Inherent STING-Stimulating Performance for Tumor Immunotherapy. [Abstract]2025 Apr;37(17):e2410998. PMID: 40095378 -
Immunity
A chemical agonist and the Golgi-resident lipid PI4P activate STING by inducing transmembrane helix rearrangement. [Abstract]2025 Dec 5:S1074-7613(25)00506-0. PMID: 41352342 -
Immunity
A metabolic switch orchestrated by IL-18 and the cyclic dinucleotide cGAMP programs intestinal tolerance. [Abstract]2024 Jun 19:S1074-7613(24)00305-4. PMID: 38906145 -
Exploration
A Bioorthogonal and Programmable Bacterial Delivery System for Spatiotemporally Targeted Therapy of Solid Tumors. [Abstract]2025 Dec 18;5(6):20240396. PMID: 41476656 -
Cell Stem Cell
Mechano-oncogenic cytoskeletal remodeling drives leukemic transformation with mitochondrial vesicle-mediated STING activation. [Abstract]2025 Apr 3;32(4):581-597.e11. PMID: 39986274 -
Nat Aging
The glycolytic metabolite phosphoenolpyruvate restricts cGAS-driven inflammation to promote healthy aging. [Abstract]2026 Apr;6(4):831-848. PMID: 41792330 -
Mol Cell
2026 Jun 18;86(12):2294-2308.e7. PMID: 42314650 -
Cancer Res
An Immune Subtype Classification System Enables the Development of Strategies to Predict and Enhance Immunotherapy Responses in Colorectal Cancer. [Abstract]2025 Apr 15;85(8):1441-1458. PMID: 39879113 -
Cancer Res
MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors. [Abstract]2021 May 15;81(10):2714-2729. PMID: 33589518
H-151 purchased from MedChemExpress. Usage Cited in: Cancer Res. 2021 May 15;81(10):2714-2729. [Abstract]
RT-qPCR analysis of CCL5, CXCL10, ISG15 and IFI44 expression in HOC7 with depletion of STING by STING inhibition (1 μM H151) for 24 hours.
-
Nat Commun
STING synergizes with TOX suppressing HO-1 expression to trigger ferroptosis in tumor-infiltrating CD8+ T cell and immunotherapy resistance. [Abstract]2026 Feb 9;17(1):2543. PMID: 41663385 -
Nat Commun
FAD synthase confers ferroptosis resistance and restrains CD8+ T cell recruitment in hepatocellular carcinoma. [Abstract]2025 Oct 29;16(1):9547. PMID: 41162372 -
Cell Death Differ
2026 Apr 1. PMID: 41917183 -
Neuron
Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis. [Abstract]2023 Jan 18;111(2):236-255.e7. PMID: 36370710 -
Adv Sci (Weinh)
PVC Nanoplastics Exposure Exacerbates Asthma through R-Loop Accumulation and Subsequent STING Activation in Macrophages. [Abstract]2025 Sep 8:e02223. PMID: 40919700 -
Adv Sci (Weinh)
T Cell-Derived Apoptotic Extracellular Vesicles Hydrolyze cGAMP to Alleviate Radiation Enteritis via Surface Enzyme ENPP1. [Abstract]2024 Jun 18:e2401634. PMID: 38888507
H-151 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Jun 18:e2401634. [Abstract]
H-151 (750 nmol in 200 µL PBS with 5% Tween-80) suppresses radiation-induced phosphorylation of TBK1 and IRF3 in the colons of C57BL/6J mice.
-
Leukemia
STING activation in TET2-mutated hematopoietic stem/progenitor cells contributes to the increased self-renewal and neoplastic transformation. [Abstract]2023 Dec;37(12):2457-2467. PMID: 37816954 -
Exp Mol Med
Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis. [Abstract]2022 Feb;54(2):129-142. PMID: 35145201 -
J Nanobiotechnology
Tumor microenvironment-responsive DNA-based nanomedicine triggers innate sensing for enhanced immunotherapy. [Abstract]2023 Oct 19;21(1):382. PMID: 37858171 -
Sci Adv
Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy. [Abstract]2025 Jul 11;11(28):eadw1553. PMID: 40644541 -
Small
Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity. [Abstract]2024 Mar;20(9):e2307448. PMID: 37845027
H-151 purchased from MedChemExpress. Usage Cited in: Small. 2024 Mar;20(9):e2307448. [Abstract]
H-151 (1-10 μM; 24 h) dose-dependently reduces 223Ra (3.7 kBq/mL; 48 h)-induced cytotoxicity in LLC cells.
H-151 purchased from MedChemExpress. Usage Cited in: Small. 2024 Mar;20(9):e2307448. [Abstract]
H-151 (1 μM; 24 h) significantly attenuates 223Ra (3.7 kBq/mL; 48 h)-induced upregulation of NLRP3 expression while increasing the cleaved GSDMD/GSDMD ratio in LLC cells.
-
Cell Rep Med
Enalaprilat reverses neutrophil polarization imbalance via targeting taurine-STING axis for treatment of diabetic wounds. [Abstract]2026 Apr 21;7(4):102714. PMID: 41916295 -
Cell Rep Med
MPXV infection activates cGAS-STING signaling and IFN-I treatment reduces pathogenicity of mpox in CAST/EiJ mice and rhesus macaques. [Abstract]2025 May 20;6(5):102135. PMID: 40398389 -
J Immunother Cancer
Bendamustine-rituximab elicits dual tumoricidal and immunomodulatory responses via cGAS-STING activation in diffuse large B-cell lymphoma. [Abstract]2024 Nov 9;12(11):e009212. PMID: 39521616 -
J Immunother Cancer
Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway. [Abstract]2024 Sep 4;12(9):e009318. PMID: 39237260 -
J Immunother Cancer
Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade. [Abstract]2023 Aug;11(8):e007035. PMID: 37620043 -
Diabetologia
Aberrant STING signalling promotes endothelial dysfunction and neurovascular injury in diabetic retinopathy. [Abstract]2025 Dec 19. PMID: 41419617 -
Cancer Lett
Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response. [Abstract]2025 Apr 29:217759. PMID: 40311913 -
J Neuroinflammation
STING inhibition suppresses microglia-mediated synapses engulfment and alleviates motor functional deficits after stroke. [Abstract]2024 Apr 8;21(1):86. PMID: 38584255 -
Int J Biol Sci
Neutrophil extracellular traps trigger alveolar epithelial cell necroptosis through the cGAS-STING pathway during acute lung injury in mice. [Abstract]2024 Sep 3;20(12):4713-4730. PMID: 39309425 -
Int J Biol Sci
Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. [Abstract]2022 Jan 1;18(2):585-598. PMID: 35002511 -
Cell Death Dis
cGAS-STING/HMGB1-mediated senescence induced by LRRK2 accelerates cartilage degeneration in osteoarthritis. [Abstract]2026 Mar 25;17(1):377. PMID: 41881967 -
Adv Healthc Mater
Ultrasound-Triggered Nanobubbles for Endothelial-Targeted Drug Delivery in the Detection and Treatment of Doxorubicin-Induced Cardiotoxicity. [Abstract]2026 Apr;15(16):e05898. PMID: 41691418 -
Cell Death Dis
STING dependent BAX-IRF3 signaling results in apoptosis during late-stage Coxiella burnetii infection. [Abstract]2024 Mar 8;15(3):195. PMID: 38459007 -
Cell Death Dis
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer. [Abstract]2024 Feb 3;15(2):110. PMID: 38310091 -
-
Proc Natl Acad Sci U S A
Activation of the NLRP1 inflammasome in human keratinocytes by the dsDNA mimetic poly(dA:dT). [Abstract]2023 Jan 31;120(5):e2213777120. PMID: 36693106 -
Cell Commun Signal
Intrinsic STING of CD8 + T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects. [Abstract]2025 Feb 19;23(1):99. PMID: 39972350 -
Cell Commun Signal
Decreased MFN2 activates the cGAS-STING pathway in diabetic myocardial ischaemia-reperfusion by triggering the release of mitochondrial DNA. [Abstract]2023 Aug 3;21(1):192. PMID: 37537600 -
Int J Biol Macromol
2024 Sep 17:135764. PMID: 39299429 -
Acta Pharmacol Sin
Microglial STING activation promotes neuroinflammation and pathological changes in experimental mice with intracerebral haemorrhage. [Abstract]2025 Apr 8. PMID: 40200123 -
Acta Pharmacol Sin
STING inhibitor ameliorates LPS-induced ALI by preventing vascular endothelial cells-mediated immune cells chemotaxis and adhesion. [Abstract]2022 Aug;43(8):2055-2066. PMID: 34907359 -
Phytomedicine
Fupenzic acid ameliorates radiation-induced liver fibrosis by regulating RBMS1 to inhibit the cGAS-STING pathway and restore mitochondrial function. [Abstract]2026 Jun 9:159:158399. PMID: 42314350 -
EMBO J
2025 Sep 1. PMID: 40890487 -
Phytomedicine
Direct inhibition of macrophage sting signaling by curcumol protects against myocardial infarction via attenuating the inflammatory response. [Abstract]2025 Jan 17:138:156403. PMID: 39889491 -
ACS Appl Mater Interfaces
Tumor Eradication via UTMC-Induced Thrombotic Infarction Combined with Redox-Responsive Nanoparticle-Mediated Chemo-Immunotherapy. [Abstract]2026 Apr 29;18(16):22999-23016. PMID: 41995720 -
Cancer Immunol Res
FAM135B Deficiency Inhibits Cytotoxic T-Cell Activity in Triple-negative Breast Cancer by Blocking the IFI16-dependent STING Pathway. [Abstract]2025 Nov 11. PMID: 41218197 -
-
Free Radic Biol Med
STING immune activation of microglia aggravating neurovascular unit damage in diabetic retinopathy. [Abstract]2025 Mar 28:S0891-5849(25)00192-3. PMID: 40158743 -
Free Radic Biol Med
Polyvinyl chloride nanoplastics suppress homology-directed repair and promote oxidative stress to induce esophageal epithelial cellular senescence and cGAS-STING-mediated inflammation. [Abstract]2025 Jan:226:288-301. PMID: 39515594 -
Free Radic Biol Med
STING promotes ferroptosis through NCOA4-dependent ferritinophagy in acute kidney injury. [Abstract]2023 Nov 1:208:348-360. PMID: 37634745 -
Sci Total Environ
Mitochondrial DNA release mediated by TFAM deficiency promotes copper-induced mitochondrial innate immune response via cGAS-STING signalling in chicken hepatocytes. [Abstract]2023 Dec 20:905:167315. PMID: 37742962 -
Chin Med J (Engl)
Transcranial photobiomodulation mitigates neuroinflammation by suppressing the activation of neurotoxic microglia through inhibition of the cGAS-STING pathway following intracerebral hemorrhage in mice. [Abstract]2026 Apr 27. PMID: 42045151 -
Cell Chem Biol
2026 Apr 27:S2451-9456(26)00110-8. PMID: 42049033 -
Aging Cell
Systemic LINE-1 RNA in Plasma Extracellular Vesicles Drives Neuroinflammation and Cognitive Dysfunction via cGAS-STING Pathway in Aging. [Abstract]2026 Jan;25(1):e70350. PMID: 41480826 -
Cell Death Discov
Iron derived from NCOA4-mediated ferritinophagy causes cellular senescence via the cGAS-STING pathway. [Abstract]2023 Nov 18;9(1):419. PMID: 37980349 -
Cell Death Discov
GSDMD promotes neutrophil extracellular traps via mtDNA-cGAS-STING pathway during lung ischemia/reperfusion. [Abstract]2023 Oct 4;9(1):368. PMID: 37794018 -
Cell Rep
The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy. [Abstract]2025 Apr 17;44(5):115605. PMID: 40249707 -
Cell Rep
The N-degron pathway mediates the autophagic degradation of cytosolic mitochondrial DNA during sterile innate immune responses. [Abstract]2024 Dec 21;44(1):115094. PMID: 39709605 -
Cell Rep
4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING. [Abstract]2023 Feb 28;42(3):112145. PMID: 36862550 -
Neural Regen Res
The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson's disease. [Abstract]2025 Aug 1;20(8):2361-2372. PMID: 39359093 -
Antioxidants (Basel)
Carnosic Acid Activates the STING/IRF3 Pathway to Induce Nitric Oxide-Mediated Apoptosis in Osteosarcoma Cells. [Abstract]2026 Mar 16;15(3):374. PMID: 41897520 -
EMBO Rep
2022 Jun 7;23(6):e53932. PMID: 35403787 -
JCI Insight
Neutrophil extracellular traps potentiate effector T cells via endothelial senescence in uveitis. [Abstract]2025 Jan 23;10(2):e180248. PMID: 39846254 -
Antioxid Redox Signal
2024 Aug 1. PMID: 39001814 -
Neurosci Bull
Inhibition of the cGAS‑STING Pathway Reduces Cisplatin-Induced Inner Ear Hair Cell Damage. [Abstract]2025 Mar;41(3):359-373. PMID: 39676140 -
Biochem Pharmacol
Ginkgetin alleviates cisplatin-induced muscle atrophy via inhibition of the macrophage cGAS-STING pathway. [Abstract]2026 Mar 8:249:117879. PMID: 41806931 -
Biochem Pharmacol
Macrophage extracellular traps impair intestinal barrier function in DSS-induced colitis in mice by inducing intestinal epithelial cell apoptosis. [Abstract]2025 Dec;242(Pt 3):117406. PMID: 41057125 -
Biochem Pharmacol
2023 Jul:213:115618. PMID: 37211172 -
-
Virulence
Mycobacterial ESAT-6 triggers cGAS-STING pathway via the GSDMD-NT dependent mitochondria dysfunction. [Abstract]2025 Dec;16(1):2570001. PMID: 41091775 -
Int J Pharm
Enhancing Tumor-Specific immunity with SLdacA: A attenuated Salmonella-mediated c-di-AMP delivery system targeting the STING pathway. [Abstract]2024 Dec 5:666:124759. PMID: 39332458 -
Int J Pharm
Chitosan derivative composite nanoparticles as adjuvants enhance the cellular immune response via activation of the cGAS-STING pathway. [Abstract]2023 Apr 5:636:122847. PMID: 36933583 -
Life Sci
Oxytocin ameliorates cardiac hypertrophy by inhibiting mitochondrial dysfunction and pyroptosis via AMPK/PGC-1α /TFAM pathway. [Abstract]2026 Apr 15:391:124281. PMID: 41722768 -
Commun Biol
Targeting STING to disrupt macrophage-mediated adhesion in encapsulating peritoneal sclerosis. [Abstract]2025 Aug 23;8(1):1266. PMID: 40847090 -
Prog Orthod
2026 Jan 13;27(1):1. PMID: 41528413 -
Int J Mol Sci
2023 Mar 7;24(6):5125. PMID: 36982193 -
Int Immunopharmacol
Codonopsis pilosula as the sovereign herb in Shenling Baizhu formula ameliorates DSS-induced ulcerative colitis via spermidine-AMPK-mediated mitophagy to inhibit the cGAS-STING inflammatory axis. [Abstract]2026 Sep 1:184:116954. PMID: 42217339 -
Int Immunopharmacol
Tempol alleviates autoimmune uveitis by targeting the oxidative stress-mediated cGAS-STING-NF-kB signaling pathway to restore M1/M2 macrophage polarization balance. [Abstract]2026 Aug 1:182:116798. PMID: 42105710 -
Int Immunopharmacol
LXRs agonists alleviate fat transplantation-induced cognitive dysfunction by inhibiting STING-dependent type I interferon response. [Abstract]2026 Mar 1:172:116229. PMID: 41558290 -
Eur J Pharmacol
STING inhibition by H-151 is associated with amelioration of psoriasis severity via modulation of pathogenic T helper cell subsets. [Abstract]2026 Feb 15:1015:178564. PMID: 41548683 -
Int Immunopharmacol
2026 Jan 1;168(Pt 2):115892. PMID: 41273847 -
Int Immunopharmacol
Mitochondrial DNA contributes to dysbiosis-associated mastitis via activation of the cGAS-STING pathway. [Abstract]2025 Oct 22:167:115717. PMID: 41130091 -
Am J Physiol Cell Physiol
Mitochondrial DNA-driven senescence-associated secretory phenotype promotes the development of bronchopulmonary dysplasia. [Abstract]2025 Sep 12. PMID: 40938804 -
Eur J Pharmacol
Iguratimod, a promising therapeutic agent for COVID-19 that attenuates excessive inflammation in mouse models. [Abstract]2025 Mar 25:177537. PMID: 40147575 -
Int Immunopharmacol
Corilagin inhibits human cytomegalovirus infection and replication via activating the cGAS-STING signaling pathway in vitro and in vivo. [Abstract]2024 Oct 17;143(Pt 2):113401. PMID: 39423664 -
Int Immunopharmacol
Endogenous retroviruses modulate the susceptibility of mice to Staphylococcus aureus-induced mastitis by activating cGAS-STING signaling. [Abstract]2024 Sep 22;142(Pt B):113171. PMID: 39312862 -
Int Immunopharmacol
tBHQ mitigates fatty liver ischemia-reperfusion injury by activating Nrf2 to attenuate hepatocyte mitochondrial damage and macrophage STING activation. [Abstract]2024 Jun 24:138:112515. PMID: 38917524 -
Eur J Pharmacol
Proteasome inhibitors FHND6091 enhance the ability of NK cells to kill tumor cells through multiple mechanisms. [Abstract]2024 Jun 5:176716. PMID: 38849039 -
Int Immunopharmacol
Bardoxolone methyl breaks the vicious cycle between M1 macrophages and senescent nucleus pulposus cells through the Nrf2/STING/NF-κB pathway. [Abstract]2024 Jan 25:127:111262. PMID: 38101216 -
Mol Pharm
Oral Lipid-Based Nanomedicine for the Inhibition of the cGAS-STING Pathway in Inflammatory Bowel Disease Treatment. [Abstract]2025 Apr 7;22(4):2108-2121. PMID: 40032274 -
Mol Oncol
2023 Dec;17(12):2584-2602. PMID: 37746742 -
Exp Gerontol
Metformin attenuates lens epithelial cell senescence by suppressing cGAS-STING via SIRT1-PGC-1α-mediated mitochondrial fission. [Abstract]2026 Jun 15:219:113157. PMID: 42069238 -
J Gen Virol
SARS-CoV-2 Nsp15 facilitates immune evasion and viral replication by limiting multiple host innate immune pathways, including cGAS-STING. [Abstract]2026 Mar;107(3):002233. PMID: 41880208 -
Drug Dev Res
Astragaloside IV Enhances Anti-PD-L1 Immunotherapy in Triple-Negative Breast Cancer by Activating the cGAS-STING Pathway. [Abstract]2026 May;87(3):e70311. PMID: 42121378 -
-
J Cell Mol Med
IFI16 Induced by p53 Activates the NF-κB Pathway to Counteract Cisplatin-Induced Apoptosis in Cervical Cancer Cells. [Abstract]2025 Aug;29(15):e70728. PMID: 40770819 -
FASEB J
2025 Apr 15;39(7):e70530. PMID: 40193045 -
FEBS J
Oxaliplatin accelerates immunogenic cell death by activating the cGAS/STING/TBK1/IRF5 pathway in gastric cancer. [Abstract]2025 Apr 22. PMID: 40260556 -
Transl Oncol
Targeted inhibition of ATR kinase promotes antitumor immunity in HNSCC through enhanced STING activation and T cell function. [Abstract]2026 Jun 19:71:102869. PMID: 42322694 -
iScience
M1-like macrophages regulate T cell infiltration in colorectal cancer through P2X4 receptor. [Abstract]2025 Sep 5;28(10):113517. PMID: 41031375 -
Eye Vis (Lond)
STING deficiency alleviates scar formation after glaucoma filtration surgery by suppressing p38 MAPK-induced inflammation in mice. [Abstract]2026 Feb 2;13(1):7. PMID: 41622229 -
Pestic Biochem Physiol
Arsenic-induced mtDNA release promotes inflammatory responses through cGAS-STING signaling in chicken hepatocytes. [Abstract]2024 Nov:205:106129. PMID: 39477583 -
Sci Rep
Gamma-aminobutyric acid transaminase mediates tumor suppression in renal cell carcinoma through the cGAS-STING-interferon-β axis. [Abstract]2026 Mar 11;16(1):13082. PMID: 41813748 -
J Virol
African Swine Fever Virus H240R Protein Inhibits the Production of Type I Interferon through Disrupting the Oligomerization of STING. [Abstract]2023 Sep 28;97(9):e0057723. PMID: 37199611 -
Clin Immunol
STING contributes to trauma-induced heterotopic ossification through NLRP3-dependent macrophage pyroptosis. [Abstract]2023 May:250:109300. PMID: 36963448 -
Front Mol Neurosci
Protein Tyrosine Phosphatase Receptor Type D Regulates Neuropathic Pain After Nerve Injury via the STING-IFN-I Pathway. [Abstract]2022 Apr 14:15:859166. PMID: 35493326 -
Cell Signal
Mitochondrial IRF3 drives pulmonary fibrosis by impairing mitophagy and triggering ferroptosis. [Abstract]2026 Aug:144:112517. PMID: 41932414 -
Cell Signal
Activation of STING pathway by mitochondrial fission negatively regulates adipogenic differentiation of 3 T3-L1 cells. [Abstract]2025 Jun 16:111948. PMID: 40532961 -
Cell Signal
STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease. [Abstract]2023 Sep:109:110777. PMID: 37329999 -
Am J Pathol
Stimulator of Interferon Genes Is a Fine-Tuner, but Not a Prime Mover, of Kidney Inflammation. [Abstract]2026 Feb;196(2):515-531. PMID: 41571339 -
Heliyon
The potential of melatonin in sepsis-associated acute kidney injury: Mitochondrial protection and cGAS-STING signaling pathway. [Abstract]2024 Dec 26;11(1):e41501. PMID: 39850412 -
Biol Trace Elem Res
The Role of the cGAS/STING Pathway in Arsenic-Induced Neurotoxicity: Insights from the Crosstalk Between Astrocytes and Neurons. [Abstract]2025 Aug;203(8):4224-4239. PMID: 39693001 -
BMC Cancer
2024 Jul 26;24(1):902. PMID: 39061024 -
J Immunol
African Swine Fever Virus MGF-505-7R Negatively Regulates cGAS-STING-Mediated Signaling Pathway. [Abstract]2021 Apr 15;206(8):1844-1857. PMID: 33712518 -
Am J Physiol Renal Physiol
The novel STING antagonist H151 ameliorates cisplatin-induced acute kidney injury and mitochondrial dysfunction. [Abstract]2021 Apr 1;320(4):F608-F616. PMID: 33615891 -
Cell Biol Int
Solute Carrier Family 19 Member 1 Mediates Acquired Bortezomib Resistance in Multiple Myeloma Through Chronic Stimulator of Interferon Genes Activation and Mitochondrial DNA Release. [Abstract]2026 Feb;50(2):e70130. PMID: 41556422 -
J Diabetes Investig
PLAGL1 overexpression exacerbates type 1 diabetes by inducing β-cell apoptosis via oxidative stress-dependent dual DNA damage and cGAS/STING pathway activation. [Abstract]2025 Nov 25. PMID: 41292300 -
Ren Fail
H-151 attenuates lipopolysaccharide-induced acute kidney injury by inhibiting the STING-TBK1 pathway. [Abstract]2024 Dec;46(2):2363591. PMID: 38856314 -
Toxicol Lett
Tributyl phosphate disrupts hepatic lipid metabolism via cGAS-STING signal pathway mediated inflammation. [Abstract]2026 Mar:417:111847. PMID: 41617062 -
3 Biotech
Resveratrol mitigated acute sleep deprivation-induced cognitive impairment by suppressing hippocampal neuronal ferroptosis. [Abstract]2025 Aug;15(8):236. PMID: 40625422 -
Toxicol Lett
Human kidney organoids model of Esculentoside A nephrotoxicity to investigate the role of epithelial-mesenchymal transition via STING signaling. [Abstract]2023 Jan 15:373:172-183. PMID: 36460195
H-151 purchased from MedChemExpress. Usage Cited in: Toxicol Lett. 2023 Jan 15:373:172-183. [Abstract]
H-151 (H151; 750 nM/mice; i.p.; every 12 h for 72 h) significantly restores inflammatory cell infiltration and ECM deposition in the mice with EsA (fig K), and decreases collagen fiber streaks (blue-stained area) (fig M).
-
BMC Pulm Med
TFNAs induce autophagy via activation of the nonclassical cGAS-STING signalling pathway to attenuate acute lung injury in mice. [Abstract]2025 Nov 7;25(1):514. PMID: 41204262 -
Neuroscience
Microbial infection instigates tau-related pathology in Alzheimer's disease via activating neuroimmune cGAS-STING pathway. [Abstract]2025 Apr 19:572:122-133. PMID: 40064364 -
-
Toxicol Mech Methods
Polystyrene nanoplastics induce pyroptosis in HepG2 cells via the YAP1-cGAS-STING signaling axis. [Abstract]2026 May;36(4):594-604. PMID: 41738323 -
Cell Biochem Funct
PINK1 Deficiency Facilitates Palmitic Acid-Induced Inflammation by Disrupting Mitochondrial Function to Activate mtDNA-cGAS-STING Signaling. [Abstract]2025 Jun;43(6):e70092. PMID: 40518699 -
Photodiagnosis Photodyn Ther
ALA-PDT induces apoptosis in HPV-transformed cells through mtDNA release-mediated activation of the cGAS-STING pathway. [Abstract]2026 Jun 2:60:105534. PMID: 42235809 -
Adv Biol (Weinh)
Activation of cGAS/STING Drives Inflammation and Cellular Senescence of Macrophages in Ovarian Endometrioma Induced by Endometriotic Cyst Fluid. [Abstract]2024 Jun 12:e2300711. PMID: 38864247 -
J Neuroimmunol
NAD+ supplement relieved chronic sleep restriction (CSR)-induced microglial proinflammation in vivo and in vitro. [Abstract]2024 Dec 15:397:578469. PMID: 39520937 -
Purinergic Signal
P2X7 receptor-mediated cGAS-STING pathway activation underlies chronic stress-induced depressive-like behaviors. [Abstract]2026 Mar 30;22(2):35. PMID: 41912731 -
J Biomol Struct Dyn
Investigating the mechanism of corilagin interfering with HSV-2 replication: an in vitro and in silico analysis of the cGAS-STING pathway. [Abstract]2025 May 27:1-14. PMID: 40432333 -
Exp Ther Med
Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway. [Abstract]2023 Feb 17;25(4):155. PMID: 36911381 -
Gastroenterol Res Pract
Neutrophil Extracellular Traps Promote Pancreatic Cancer Progression via the STING Pathway. [Abstract]2025 Feb 26:2025:4950214. PMID: 40046958 -
bioRxiv
2026 May 25:2026.05.24.727547. PMID: 42244575 -
bioRxiv
2026 May 29:2026.05.26.727520. PMID: 42244578 -
bioRxiv
It's Not Rewarding for Mitochondria: Dopamine-Induced Mitochondrial Dysfunction Activates cGAS-STING to Drive IL-6 Secretion in Macrophages. [Abstract]2026 Apr 25:2026.04.23.719926. PMID: 42079251 -
-
-
-
-
-
-
Cell Insight
2025 May 22;4(4):100255. PMID: 40586041 -
-
bioRxiv
Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers. [Abstract]2025 Feb 5:2025.01.31.635709. PMID: 39975048 -
-
bioRxiv
2024 Sep 5:2024.09.05.611469. PMID: 39282446 -
-
bioRxiv
KAT2 paralogs prevent dsRNA accumulation and interferon signaling to maintain intestinal stem cells. [Abstract]2023 Sep 5:2023.09.04.556156. PMID: 37732252 -
-
-
Solvent & Solubility
DMSO : 100 mg/mL (357.99 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (7.45 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2.08 mg/mL (7.45 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (274 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.5799 mL | 17.8993 mL | 35.7987 mL | 89.4967 mL |
| 5 mM | 0.7160 mL | 3.5799 mL | 7.1597 mL | 17.8993 mL | |
| 10 mM | 0.3580 mL | 1.7899 mL | 3.5799 mL | 8.9497 mL | |
| 15 mM | 0.2387 mL | 1.1933 mL | 2.3866 mL | 5.9664 mL | |
| 20 mM | 0.1790 mL | 0.8950 mL | 1.7899 mL | 4.4748 mL | |
| 25 mM | 0.1432 mL | 0.7160 mL | 1.4319 mL | 3.5799 mL | |
| 30 mM | 0.1193 mL | 0.5966 mL | 1.1933 mL | 2.9832 mL | |
| 40 mM | 0.0895 mL | 0.4475 mL | 0.8950 mL | 2.2374 mL | |
| 50 mM | 0.0716 mL | 0.3580 mL | 0.7160 mL | 1.7899 mL | |
| 60 mM | 0.0597 mL | 0.2983 mL | 0.5966 mL | 1.4916 mL | |
| 80 mM | 0.0447 mL | 0.2237 mL | 0.4475 mL | 1.1187 mL | |
| 100 mM | 0.0358 mL | 0.1790 mL | 0.3580 mL | 0.8950 mL |